Hyaluronic acid modified z pH-sensitive nanovector for targeted intracellular delivery of cytotoxic agent
useful targeted drug carrier to treat CD44-expressing breast tumors. PDF HTML
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
useful targeted drug carrier to treat CD44-expressing breast tumors. PDF HTML
software programs may be the integral part of anticoagulation management services in TASH. PDF HTML
formulating multi-compartment dosage form of fixed doses of three anti-hypertensive drugs. PDF HTML
promising carrier for the transportation of insulin across the intestine on oral administration. PDF HTML
approach to improve oral bioavailability of BCS class-IV drug like exemestane HCL. PDF HTML
developed as a platform for delivery of pH dependent poorly soluble drugs. PDF HTML
this delivery system is an excellent candidate for local buccal delivery. PDF HTML
nobilis L. wood and were identified using chemical, conventional and advanced spectral techniques. PDF HTML
increase in relative bioavailability of TIZ from the optimized formula was 2.27 fold. PDF HTML
have good solubility in the relatively non-toxic solvent like CH2Cl2, CHCl3 etc. PDF HTML
which help in increasing drug concentration in cytosol by lysing the endosomal layer. PDF HTML
isoquinoline alkaloids were evaluated for their potential antiviral activity against HBV in vitro. PDF HTML
release and their potential to be used as drug-release-sustaining pharmaceutical excipient. PDF HTML
drug over a period of 12 hr in a sustained manner in vitro. PDF HTML
time, money and attention must be given to the treatment of diabetic patients. PDF HTML
determine their precipitation activity and applicability as a mass spectrometry introductory tool. PDF HTML
required in order to reduce its risk factors and decrease its prevalence. PDF HTML
proper management and an active intervention is needed in order to control obesity. PDF HTML
toxicity of propofol, presumably by scavenging ROS and/or reducing ROS production. PDF HTML
technology for the in vivo systemic delivery of peptides and non modified siRNAs. PDF HTML
long history of pharmaceutical use with no issues about toxicology or API stability. PDF HTML
parameters and a map of nano-carrier design guidelines are developed and presented. PDF HTML
promising approach in chemotherapy, overcoming the toxic effects of the known aqueous drugs. PDF HTML
bioavailability of chemotherapeutic drug and in vivo therapeutic efficiency is examined in progress. PDF HTML
amount of each drug and to achieve the synergistic effect for cancer therapies. PDF HTML
For authors and organisers
Find the right journal for your paper and submit your manuscript.